MAQUET Cardiovascular initiates study evaluating EVH in CABG compared to open vein harvesting

MAQUET Cardiovascular LLC, a leading provider of cardiovascular technologies, today announced the initiation of the OPTION (Optimal Improvement of Vein Graft Patency Long Term by the Implementation Of Novel Endoscopic Harvesting Techniques) study. This clinical trial is designed to evaluate the equivalence of Endoscopic Vessel Harvesting (EVH) in Coronary Artery Bypass Graft (CABG) surgery compared with historical data for open vein harvesting.  David Moore, M.D., of THE HEART HOSPITAL Baylor Plano is the principal investigator for the OPTION trial.

"We believe the OPTION study will address the shortcomings of previous studies evaluating EVH in CABG.  The study will emphasize the importance of standardization in harvest procedure, operator experience and medical management, and provide a more contemporary representation of the quality of conduit harvested with the EVH technique," said Michael J. Mack, M.D., Research Director, THE HEART HOSPITAL Baylor Plano.  

OPTION is a 100-patient, single-center study that will evaluate vein graft patency at one month and one year following CABG surgery.  The study standardizes a number of pre- and post-harvesting factors and will utilize the VASOVIEW HEMOPRO technology system, as well as experienced harvesters with the appropriate skill level to best preserve and protect the vessel.  

"The OPTION study underscores MAQUET Cardiovascular's commitment to advancing EVH instrumentation and procedures as well as advancing the dialogue among cardiovascular surgeons about the benefits of EVH," said Luca Lombardi, M.D., Chief Medical Officer of MAQUET Cardiovascular.  "We believe the OPTION study's scientific rigor will validate the safety and efficacy of EVH, without subjecting patients to complications associated with open harvesting techniques that a randomized study would require."

SOURCE MAQUET Cardiovascular LLC

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Low-level arsenic exposure in water linked to increased heart disease risk